Anticoagulants

Global Industry Analysts
October 1, 2012
434 Pages - SKU: GJOB4921030
Congestive Heart Failure (Heart Failure)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Congestive Heart Failure (Heart Failure)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Congestive Heart Failure (Heart Failure)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III  |  read more...
USD 2,000
Thalassemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Thalassemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Thalassemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Thalassemia.  |  read more...
USD 2,000
Acute Heart Failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Acute Heart Failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Acute Heart Failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed  |  read more...
USD 2,000
Dyslipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Dyslipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Dyslipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Dyslipidemia.  |  read more...
USD 2,000
Hemophilia A-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Hemophilia A-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Hemophilia A-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Post-Myocardial Infarction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Post-Myocardial Infarction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Post-Myocardial Infarction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Chronic Heart Failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Chronic Heart Failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Chronic Heart Failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed  |  read more...
USD 2,000
Hemophilia B-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Hemophilia B-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Hemophilia B-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Mixed Dyslipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Mixed Dyslipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Mixed Dyslipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Global Atrial Fibrillation Market 2015-2019
1/28/2015 | published by: TechNavio - Infiniti Research Ltd.
Global Atrial Fibrillation Market 2015-2019 About Atrial Fibrillation According to the NHLBI of the NIH in the US, atrial fibrillation is one of the commonest type of arrhythmia. Atrial fibrillation is similar to another type of arrhythmia  |  read more...
USD 2,500
 

SELECT A LICENSE

    PDF E-mail From Publisher  USD 4,950  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!